225Ac-Macropa-PEG4-YS5

N/A

Report date: 2025/10/21 15:09:13

Base Information

Drug Name225Ac-Macropa-PEG4-YS5

Drug Alias NameActinium[225Ac]Macropa-PEG4-YS5

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionMembrane cofactor protein modulators

TargetsMembrane cofactor protein

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California San Francisco

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San Francisco

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A